GB1440602A - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
GB1440602A
GB1440602A GB2306575A GB2306575A GB1440602A GB 1440602 A GB1440602 A GB 1440602A GB 2306575 A GB2306575 A GB 2306575A GB 2306575 A GB2306575 A GB 2306575A GB 1440602 A GB1440602 A GB 1440602A
Authority
GB
United Kingdom
Prior art keywords
formula
cyclopenta
tetrahydropyranyl
furan
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2306575A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1440602A publication Critical patent/GB1440602A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1440602 Cyclopenta[b]furans PFIZER Inc 30 May 1973 [2 June 1972 30 April 1973] 23065/75 Divided out of 1440601 Heading C2C The invention comprises cyclopenta[b]furans of the formulµ wherein n is 0, 1 or 2; m is 0, 1, 2, 3 or 4; R 1 <SP>1</SP> is -COR 2 , wherein R 2 is C 1-5 alkyl, phenyl or p-biphenylyl; R is H or C 1-3 alkyl; R 1 is H, 2- tetrahydropyranyl or COR 2 ; and R 3 is H or 2-tetrahydropyranyl, with the proviso that when R 3 is 2-tetrahydropyranyl, R 1 is also 2- tetrahydropyranyl, and their preparation. The cyclopenta[b]furan-2-ols of Formula III above are prepared by reducing the corresponding cyclopenta[b]furan-2-ones of Formula II in which R 1 and R 3 are 2-tetrahydropyranyl, obtained by etherifying the corresponding compounds of Formula II in which R 1 and R 3 are both hydrogen, which are made by hydrolysing the corresponding cyclopenta[b]furan-2-ones of Formula II in which R 3 is 11 and R 1 is -COR 2 , the latter being obtained by either reducing the diketones of Formula I with sodium borohydride and separating the desired α-hydroxy isomers or by reacting the diketones of Formula I with C 1-3 alkyl lithiums and separating the desired α-hydroxy isomers. Diketones of Formula I are prepared by reacting phosphonates of the formula (CH 3 O) 2 PO.CH 2 .CO.(CH 2 ) 2 (CH 2 ) n O(CH 2 )mCH 3 with the appropriate 5α-acyloxy-3,3a#,4,5,6,- 6α# - hexahydro - 2 - oxo - 2H - cyclopenta[b]- furan - 4# - carboxaldehydes. Cyclopenta[b]- furan-2-ones of Formula IV above are obtained by hydrogenating the corresponding cyclopenta[b]furan-2-ones of Formula II in which R 1 and R 3 are both 2-tetrahydropyranyl.
GB2306575A 1972-06-02 1973-05-30 Cyclopentane derivatives Expired GB1440602A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (1)

Publication Number Publication Date
GB1440602A true GB1440602A (en) 1976-06-23

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
GB2306575A Expired GB1440602A (en) 1972-06-02 1973-05-30 Cyclopentane derivatives
GB2306775A Expired GB1440603A (en) 1972-06-02 1973-05-30 Alkyl phosphonates
GB2584673A Expired GB1440601A (en) 1972-06-02 1973-05-30 Oxaprostaglandins

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB2306775A Expired GB1440603A (en) 1972-06-02 1973-05-30 Alkyl phosphonates
GB2584673A Expired GB1440601A (en) 1972-06-02 1973-05-30 Oxaprostaglandins

Country Status (19)

Country Link
JP (3) JPS5314062B2 (en)
AR (2) AR199300A1 (en)
CA (1) CA1095034A (en)
CH (3) CH590224A5 (en)
DD (2) DD124594A5 (en)
DE (2) DE2327813A1 (en)
DK (1) DK143498C (en)
ES (2) ES441002A1 (en)
FI (1) FI55995C (en)
GB (3) GB1440602A (en)
IE (1) IE38568B1 (en)
IL (2) IL42373A (en)
IN (1) IN138739B (en)
LU (1) LU67738A1 (en)
NL (1) NL162902C (en)
NO (1) NO145438C (en)
PH (3) PH11300A (en)
SE (4) SE415756B (en)
YU (1) YU36497B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (en) * 1972-07-13 1976-03-01 Pfizer 15-substituted-omega-pentanorprostaglandins
US11756356B2 (en) 2019-08-28 2023-09-12 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
YU146973A (en) 1982-02-25
SE7608222L (en) 1976-07-19
DE2344838B2 (en) 1981-04-09
IL50311A (en) 1977-08-31
NL162902C (en) 1980-07-15
SE418857B (en) 1981-06-29
GB1440601A (en) 1976-06-23
DD124594A5 (en) 1977-03-02
DD109859A5 (en) 1974-11-20
DK143498B (en) 1981-08-31
IE38568L (en) 1973-12-02
SE7608221L (en) 1976-07-19
CH589074A5 (en) 1977-06-30
FI55995B (en) 1979-07-31
FI55995C (en) 1979-11-12
IL42373A0 (en) 1973-07-30
NO740849L (en) 1973-12-04
JPS5231054A (en) 1977-03-09
JPS4954349A (en) 1974-05-27
CH586716A5 (en) 1977-04-15
DE2344839B2 (en) 1976-06-24
JPS5728706B2 (en) 1982-06-18
DE2344838A1 (en) 1973-12-20
ES441003A1 (en) 1977-03-16
NO145438B (en) 1981-12-14
LU67738A1 (en) 1973-12-10
IE38568B1 (en) 1978-04-12
PH11931A (en) 1978-09-13
PH12035A (en) 1978-10-16
DE2344838C3 (en) 1982-03-18
PH11300A (en) 1977-11-02
NL162902B (en) 1980-02-15
DE2344839A1 (en) 1974-02-28
IN138739B (en) 1976-03-27
AU5639373A (en) 1974-12-05
CH590224A5 (en) 1977-07-29
NL7307740A (en) 1973-12-04
NO145438C (en) 1982-03-24
IL42373A (en) 1977-08-31
JPS5314062B2 (en) 1978-05-15
AR199300A1 (en) 1974-08-23
GB1440603A (en) 1976-06-23
SE415756B (en) 1980-10-27
YU36497B (en) 1984-02-29
ES441002A1 (en) 1977-03-01
DE2327813A1 (en) 1973-12-20
DK143498C (en) 1982-01-11
SE7608223L (en) 1976-07-19
CA1095034A (en) 1981-02-03
AR203386A1 (en) 1975-09-08
JPS5239629A (en) 1977-03-28

Similar Documents

Publication Publication Date Title
GB1416660A (en) Preparation of alicylic compounds useful as perfuming and flavouring agents
SE7408248L (en)
GB1313646A (en) Process for producing 3-phenyl pentenals
ES8301961A1 (en) Benzo(b)thiophenes.
GB1459564A (en) Alkylphenyl benzopyrans
GB1440602A (en) Cyclopentane derivatives
GB1274744A (en) Novel naphthyl acetaldehydes and derivatives thereof
ES8306765A1 (en) Novel anthracycline derivative, process for production thereof, and pharmaceutical composition comprising said compound.
ES403209A1 (en) Novel acetophenone oxime derivatives
GB1472131A (en) Alkyl derivatives of prostanoic acids and preparation thereof
GB1350883A (en) Bis-stilbene compounds
GB1396207A (en) Prostaglandin intermediates and the preparation thereof
ES444369A1 (en) Dienic derivatives of the androstane series and process
GB1388180A (en) Acetals
GB1449147A (en) Prostaglandin intermediates method for electro coating metal surfaces with carbon
GB1346289A (en) Cyclopentanone derivatives
ES460829A1 (en) 21-acetals and mixed acetals of steroidal 21-aldehydes, intermediates and methods of preparation
GB1532551A (en) Furo(3,4-6)furone derivatives and their preparation
GB1421555A (en) Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives
ES8201120A1 (en) Basic ethers of 4-hydroxy-benzophenones acting as beta-blocking agents
GB1381207A (en) Ketones
FR2381013A1 (en) PROCESS FOR PREPARING HYDROQUINONE DIMETHYL ETHER
IE38665B1 (en) 2,2,10,17-tetramethyl steroids a process for their preparation and compositions containing them
GB1446343A (en) Cyclopenta-6-furan derivatives
GB858784A (en) Water-soluble methylhesperidins and their production

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee